APO Research
Talk to an analyst

APO RESEARCH · REPORT

Demerol (Meperidine)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Demerol (Meperidine) Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchDemerol (Meperidine) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Demerol (Meperidine) Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Demerol (Meperidine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Demerol (Meperidine) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Demerol (Meperidine) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Demerol (Meperidine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Demerol (Meperidine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Demerol (Meperidine) include Sun Pharmaceuticals, Sanofi, Pfizer, Purdue Pharma, Mallinckrodt Pharmaceuticals, Janssen, Endo Pharmaceuticals, Egalet and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Demerol (Meperidine) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Demerol (Meperidine) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Demerol (Meperidine) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Demerol (Meperidine).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Demerol (Meperidine) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Demerol (Meperidine) Market by Company

Sun Pharmaceuticals

Sanofi

Pfizer

Purdue Pharma

Mallinckrodt Pharmaceuticals

Janssen

Endo Pharmaceuticals

Egalet

Boehringer Ingelheim

Actavis

Demerol (Meperidine) Segment by Type

Powder

Liquid

Demerol (Meperidine) Segment by Application

Diarrhea Treatment

Cough Treatment

Anesthesia

Demerol (Meperidine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Demerol (Meperidine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Demerol (Meperidine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Demerol (Meperidine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Demerol (Meperidine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Demerol (Meperidine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Liquid Table 3. Global Demerol (Meperidine) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 5. Global Demerol (Meperidine) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Demerol (Meperidine) Sales Market Share in Value by Type (2021-2026) Table 8. Global Demerol (Meperidine) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Demerol (Meperidine) Sales by Type (2027-2032) & (K Units) Table 10. Global Demerol (Meperidine) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Demerol (Meperidine) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Demerol (Meperidine) Sales Market Share in Value by Type (2027-2032) Table 13. Global Demerol (Meperidine) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 15. North America Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 17. Europe Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Demerol (Meperidine) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Demerol (Meperidine) Sales by Type (2021-2026) & (US$ Million) Table 24. Demerol (Meperidine) Industry Trends Table 25. Demerol (Meperidine) Industry Drivers Table 26. Demerol (Meperidine) Industry Opportunities and Challenges Table 27. Demerol (Meperidine) Industry Restraints Table 28. Global Demerol (Meperidine) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Demerol (Meperidine) Revenue Market Share by Company (2021-2026) Table 30. Global Demerol (Meperidine) Sales by Company (2021-2026) & (K Units) Table 31. Global Demerol (Meperidine) Sales Share by Company (2021-2026) Table 32. Global Demerol (Meperidine) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Demerol (Meperidine) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Demerol (Meperidine) Major Company Production Sites and Headquarters Table 35. Global Demerol (Meperidine) Company, Product Type & Application Table 36. Global Demerol (Meperidine) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Demerol (Meperidine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Demerol (Meperidine) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Demerol (Meperidine) Sales by Region (2021-2026) & (K Units) Table 41. Global Demerol (Meperidine) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Demerol (Meperidine) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Demerol (Meperidine) Sales Market Share in Value by Region (2021-2026) Table 44. Global Demerol (Meperidine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Demerol (Meperidine) Sales by Region (2027-2032) & (K Units) Table 46. Global Demerol (Meperidine) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Demerol (Meperidine) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Demerol (Meperidine) Sales Market Share in Value by Region (2027-2032) Table 49. Global Demerol (Meperidine) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Demerol (Meperidine) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 52. Global Demerol (Meperidine) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Demerol (Meperidine) Sales Market Share in Value by Application (2021-2026) Table 55. Global Demerol (Meperidine) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Demerol (Meperidine) Sales by Application (2027-2032) & (K Units) Table 57. Global Demerol (Meperidine) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Demerol (Meperidine) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Demerol (Meperidine) Sales Market Share in Value by Application (2027-2032) Table 60. Global Demerol (Meperidine) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 62. North America Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 64. Europe Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Demerol (Meperidine) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Demerol (Meperidine) Sales by Application (2021-2026) & (US$ Million) Table 71. Sun Pharmaceuticals Company Information Table 72. Sun Pharmaceuticals Business Overview Table 73. Sun Pharmaceuticals Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sun Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 75. Sun Pharmaceuticals Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Demerol (Meperidine) Product Portfolio Table 80. Sanofi Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Demerol (Meperidine) Product Portfolio Table 85. Pfizer Recent Development Table 86. Purdue Pharma Company Information Table 87. Purdue Pharma Business Overview Table 88. Purdue Pharma Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Purdue Pharma Demerol (Meperidine) Product Portfolio Table 90. Purdue Pharma Recent Development Table 91. Mallinckrodt Pharmaceuticals Company Information Table 92. Mallinckrodt Pharmaceuticals Business Overview Table 93. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 95. Mallinckrodt Pharmaceuticals Recent Development Table 96. Janssen Company Information Table 97. Janssen Business Overview Table 98. Janssen Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Janssen Demerol (Meperidine) Product Portfolio Table 100. Janssen Recent Development Table 101. Endo Pharmaceuticals Company Information Table 102. Endo Pharmaceuticals Business Overview Table 103. Endo Pharmaceuticals Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Endo Pharmaceuticals Demerol (Meperidine) Product Portfolio Table 105. Endo Pharmaceuticals Recent Development Table 106. Egalet Company Information Table 107. Egalet Business Overview Table 108. Egalet Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Egalet Demerol (Meperidine) Product Portfolio Table 110. Egalet Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Demerol (Meperidine) Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. Actavis Company Information Table 117. Actavis Business Overview Table 118. Actavis Demerol (Meperidine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Actavis Demerol (Meperidine) Product Portfolio Table 120. Actavis Recent Development Table 121. North America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 123. North America Demerol (Meperidine) Sales Market Share by Country (2021-2026) Table 124. North America Demerol (Meperidine) Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Demerol (Meperidine) Sales Market Share Forecast by Country (2027-2032) Table 126. North America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Demerol (Meperidine) Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Demerol (Meperidine) Market Share by Country (2021-2026) Table 129. North America Demerol (Meperidine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Demerol (Meperidine) Market Share Forecast by Country (2027-2032) Table 131. Europe Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 133. Europe Demerol (Meperidine) Sales Market Share by Country (2021-2026) Table 134. Europe Demerol (Meperidine) Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Demerol (Meperidine) Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Demerol (Meperidine) Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Demerol (Meperidine) Market Share by Country (2021-2026) Table 139. Europe Demerol (Meperidine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Demerol (Meperidine) Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Demerol (Meperidine) Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Demerol (Meperidine) Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Demerol (Meperidine) Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Demerol (Meperidine) Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Demerol (Meperidine) Market Share by Country (2021-2026) Table 149. Asia-Pacific Demerol (Meperidine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Demerol (Meperidine) Market Share Forecast by Country (2027-2032) Table 151. Latin America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 153. Latin America Demerol (Meperidine) Sales Market Share by Country (2021-2026) Table 154. Latin America Demerol (Meperidine) Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Demerol (Meperidine) Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Demerol (Meperidine) Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Demerol (Meperidine) Market Share by Country (2021-2026) Table 159. Latin America Demerol (Meperidine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Demerol (Meperidine) Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Demerol (Meperidine) Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Demerol (Meperidine) Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Demerol (Meperidine) Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Demerol (Meperidine) Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Demerol (Meperidine) Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Demerol (Meperidine) Market Share by Country (2021-2026) Table 169. Middle East and Africa Demerol (Meperidine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Demerol (Meperidine) Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Demerol (Meperidine) Distributors List Table 174. Demerol (Meperidine) Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Demerol (Meperidine) Image Figure 2. Global Demerol (Meperidine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Demerol (Meperidine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Demerol (Meperidine) Sales (2021-2032) & (K Units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (K Units) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Demerol (Meperidine) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Demerol (Meperidine) Market Share by Type 2025 VS 2032 Figure 11. North America Demerol (Meperidine) Sales Market Share in Volume by Type in 2025 Figure 12. North America Demerol (Meperidine) Sales Market Share in Value by Type in 2025 Figure 13. Europe Demerol (Meperidine) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Demerol (Meperidine) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Demerol (Meperidine) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Demerol (Meperidine) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Demerol (Meperidine) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Demerol (Meperidine) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Demerol (Meperidine) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Demerol (Meperidine) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Demerol (Meperidine) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Diarrhea Treatment Image Figure 24. Global Diarrhea Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cough Treatment Image Figure 26. Global Cough Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 27. Anesthesia Image Figure 28. Global Anesthesia Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Demerol (Meperidine) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Demerol (Meperidine) Market Share by Application 2025 VS 2032 Figure 31. North America Demerol (Meperidine) Sales Market Share in Volume by Application in 2025 Figure 32. North America Demerol (Meperidine) Sales Market Share in Value by Application in 2025 Figure 33. Europe Demerol (Meperidine) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Demerol (Meperidine) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Demerol (Meperidine) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Demerol (Meperidine) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Demerol (Meperidine) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Demerol (Meperidine) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Demerol (Meperidine) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Demerol (Meperidine) Sales Market Share in Value by Application in 2025 Figure 41. North America Demerol (Meperidine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Demerol (Meperidine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Demerol (Meperidine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Demerol (Meperidine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Demerol (Meperidine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Demerol (Meperidine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Demerol (Meperidine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Demerol (Meperidine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Demerol (Meperidine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Demerol (Meperidine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Demerol (Meperidine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Demerol (Meperidine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Demerol (Meperidine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Demerol (Meperidine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Demerol (Meperidine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Demerol (Meperidine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Demerol (Meperidine) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Demerol (Meperidine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Demerol (Meperidine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Demerol (Meperidine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Demerol (Meperidine) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Demerol (Meperidine) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Diarrhea Treatment
  • Cough Treatment
  • Anesthesia
Companies covered
  • Sun Pharmaceuticals
  • Sanofi
  • Pfizer
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Janssen
  • Endo Pharmaceuticals
  • Egalet
  • Boehringer Ingelheim
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Demerol (Meperidine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Demerol (Meperidine) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Demerol (Meperidine) Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Demerol (Meperidine) Market Size by Type
  9. 1.4.1 Global Demerol (Meperidine) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Demerol (Meperidine) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Demerol (Meperidine) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Demerol (Meperidine) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Demerol (Meperidine) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Demerol (Meperidine) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Demerol (Meperidine) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Demerol (Meperidine) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Demerol (Meperidine) Industry Trends
  2. 2.2 Demerol (Meperidine) Industry Drivers
  3. 2.3 Demerol (Meperidine) Industry Opportunities and Challenges
  4. 2.4 Demerol (Meperidine) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Demerol (Meperidine) Revenue (2021-2026)
  2. 3.2 Global Top Players by Demerol (Meperidine) Sales (2021-2026)
  3. 3.3 Global Top Players by Demerol (Meperidine) Price (2021-2026)
  4. 3.4 Global Demerol (Meperidine) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Demerol (Meperidine) Major Company Production Sites & Headquarters
  6. 3.6 Global Demerol (Meperidine) Company, Product Type & Application
  7. 3.7 Global Demerol (Meperidine) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Demerol (Meperidine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Demerol (Meperidine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Demerol (Meperidine) Tier 1, Tier 2, and Tier 3
4 Demerol (Meperidine) Regional Status and Outlook
  1. 4.1 Global Demerol (Meperidine) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Demerol (Meperidine) Historic Market Size by Region
  3. 4.2.1 Global Demerol (Meperidine) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Demerol (Meperidine) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Demerol (Meperidine) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Demerol (Meperidine) Forecasted Market Size by Region
  7. 4.3.1 Global Demerol (Meperidine) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Demerol (Meperidine) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Demerol (Meperidine) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Demerol (Meperidine) by Application
  1. 5.1 Demerol (Meperidine) Market by Application
  2. 5.1.1 Diarrhea Treatment
  3. 5.1.2 Cough Treatment
  4. 5.1.3 Anesthesia
  5. 5.2 Global Demerol (Meperidine) Market Size by Application
  6. 5.2.1 Global Demerol (Meperidine) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Demerol (Meperidine) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Demerol (Meperidine) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Demerol (Meperidine) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Demerol (Meperidine) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Demerol (Meperidine) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Demerol (Meperidine) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Demerol (Meperidine) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceuticals
  2. 6.1.1 Sun Pharmaceuticals Company Information
  3. 6.1.2 Sun Pharmaceuticals Business Overview
  4. 6.1.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceuticals Demerol (Meperidine) Product Portfolio
  6. 6.1.5 Sun Pharmaceuticals Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Demerol (Meperidine) Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Demerol (Meperidine) Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Purdue Pharma
  20. 6.4.1 Purdue Pharma Company Information
  21. 6.4.2 Purdue Pharma Business Overview
  22. 6.4.3 Purdue Pharma Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Purdue Pharma Demerol (Meperidine) Product Portfolio
  24. 6.4.5 Purdue Pharma Recent Developments
  25. 6.5 Mallinckrodt Pharmaceuticals
  26. 6.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 6.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 6.5.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Product Portfolio
  30. 6.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 6.6 Janssen
  32. 6.6.1 Janssen Company Information
  33. 6.6.2 Janssen Business Overview
  34. 6.6.3 Janssen Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Janssen Demerol (Meperidine) Product Portfolio
  36. 6.6.5 Janssen Recent Developments
  37. 6.7 Endo Pharmaceuticals
  38. 6.7.1 Endo Pharmaceuticals Company Information
  39. 6.7.2 Endo Pharmaceuticals Business Overview
  40. 6.7.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Endo Pharmaceuticals Demerol (Meperidine) Product Portfolio
  42. 6.7.5 Endo Pharmaceuticals Recent Developments
  43. 6.8 Egalet
  44. 6.8.1 Egalet Company Information
  45. 6.8.2 Egalet Business Overview
  46. 6.8.3 Egalet Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Egalet Demerol (Meperidine) Product Portfolio
  48. 6.8.5 Egalet Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Demerol (Meperidine) Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
  55. 6.10 Actavis
  56. 6.10.1 Actavis Company Information
  57. 6.10.2 Actavis Business Overview
  58. 6.10.3 Actavis Demerol (Meperidine) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Actavis Demerol (Meperidine) Product Portfolio
  60. 6.10.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Demerol (Meperidine) Sales by Country
  2. 7.1.1 North America Demerol (Meperidine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Demerol (Meperidine) Sales by Country (2021-2026)
  4. 7.1.3 North America Demerol (Meperidine) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Demerol (Meperidine) Market Size by Country
  6. 7.2.1 North America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Demerol (Meperidine) Market Size by Country (2021-2026)
  8. 7.2.3 North America Demerol (Meperidine) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Demerol (Meperidine) Sales by Country
  2. 8.1.1 Europe Demerol (Meperidine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Demerol (Meperidine) Sales by Country (2021-2026)
  4. 8.1.3 Europe Demerol (Meperidine) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Demerol (Meperidine) Market Size by Country
  6. 8.2.1 Europe Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Demerol (Meperidine) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Demerol (Meperidine) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Demerol (Meperidine) Sales by Country
  2. 9.1.1 Asia-Pacific Demerol (Meperidine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Demerol (Meperidine) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Demerol (Meperidine) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Demerol (Meperidine) Market Size by Country
  6. 9.2.1 Asia-Pacific Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Demerol (Meperidine) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Demerol (Meperidine) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Demerol (Meperidine) Sales by Country
  2. 10.1.1 South America Demerol (Meperidine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Demerol (Meperidine) Sales by Country (2021-2026)
  4. 10.1.3 South America Demerol (Meperidine) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Demerol (Meperidine) Market Size by Country
  6. 10.2.1 South America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Demerol (Meperidine) Market Size by Country (2021-2026)
  8. 10.2.3 South America Demerol (Meperidine) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Demerol (Meperidine) Sales by Country
  2. 11.1.1 Middle East and Africa Demerol (Meperidine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Demerol (Meperidine) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Demerol (Meperidine) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Demerol (Meperidine) Market Size by Country
  6. 11.2.1 Middle East and Africa Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Demerol (Meperidine) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Demerol (Meperidine) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Demerol (Meperidine) Value Chain Analysis
  2. 12.1.1 Demerol (Meperidine) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Demerol (Meperidine) Production Mode & Process
  7. 12.2 Demerol (Meperidine) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Demerol (Meperidine) Distributors
  10. 12.2.3 Demerol (Meperidine) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst